Can a 12-Week online course help babies with SMA develop better?

NCT ID NCT07547189

Completed Symptom relief Sponsor: Medipol University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study tests a 12-week online program for mothers of infants (12-36 months old) with SMA Type 1. The program aims to teach mothers how to support their baby's development and improve their own knowledge. Thirteen mothers will take part, with 10 receiving the program and 3 receiving standard care. Researchers will measure the babies' developmental progress and the mothers' understanding of child development.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Online Early Intervention Program for Infants with SMA Type 1
What this could lead to: If it works, this could provide a practical way for mothers to help their infants with SMA reach developmental milestones and improve their own understanding of child development.
What could go wrong: This is a very small pilot study with only 13 participants, so results may not apply to others. The program is behavioral support, not a medical treatment, and may not change the underlying disease course.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEVELOPMENTAL DELAY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

learning disability spinal muscular atrophy spinal muscular atrophy, type 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEVELOPMENTAL DELAY SPINAL MUSCULAR ATROPHY

Contacts and locations

Locations

ISTANBUL MEDIPOL UNIVERSITY - Department of Child Development

Istanbul, Beykoz, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.